BRISBANE, Calif., Aug. 08, 2025 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that, on August 4, 2025, the Compensation Committee of Vera’s Board of Directors granted inducement awards consisting of non-qualified stock options to purchase 99,000 shares of Class A common stock and restricted stock units (RSUs) underlying 48,200 shares of Class A common stock to eight (8) new employees under the Vera Therapeutics, Inc. 2024 Inducement Plan (Inducement Plan). The Compensation Committee approved the awards as an inducement material to the new employees’ employment in accordance with Nasdaq Listing Rule 5635(c)(4).
WASHINGTON, Aug. 8, 2025 /PRNewswire/ -- Growth Energy—the leading voice of America's biofuel industry—is commemorating the 20th anniversary of the Renewable Fuel Standard (RFS), which...
SHANGHAI, Aug. 8, 2025 /PRNewswire/ -- Montage Technology today announced customer sampling of its clock buffer and spread-spectrum oscillator products, following the successful mass...
New Purpose-Built School to Welcome Students in August 2025
LYNCHBURG, Va., Aug. 8, 2025 /PRNewswire/ -- Rivermont Schools invites community members, families, and district partners...
SAN FRANCISCO, Aug 8, 2025 /PRNewswire/ -- According to a new market research report titled "Transparent Ceramics Market Forecast to 2031 – Global and Regional...
SAN FRANCISCO, Aug 8, 2025 /PRNewswire/ -- According to a new market research report titled "Transparent Ceramics Market Forecast to 2031 – Global and Regional...
- Strategic investment to support RBL's mission to launch and scale breakthrough startups
- Founder and general partner of Modi Ventures, Sahir Ali, to join...